Luoqi Jia

550 total citations
13 papers, 452 citations indexed

About

Luoqi Jia is a scholar working on Molecular Biology, Epidemiology and Pharmacology. According to data from OpenAlex, Luoqi Jia has authored 13 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Pharmacology. Recurrent topics in Luoqi Jia's work include Autophagy in Disease and Therapy (3 papers), Phytochemistry and Bioactivity Studies (3 papers) and Cancer Mechanisms and Therapy (2 papers). Luoqi Jia is often cited by papers focused on Autophagy in Disease and Therapy (3 papers), Phytochemistry and Bioactivity Studies (3 papers) and Cancer Mechanisms and Therapy (2 papers). Luoqi Jia collaborates with scholars based in China and United States. Luoqi Jia's co-authors include Hongyan Jin, Yinhua Yu, Yiling Lu, Youji Feng, Jiayi Zhou, Yinhua Yu, Yadi Wu, Tao Zhang, Binhua P. Zhou and Jiayi Zhou and has published in prestigious journals such as Cancer Research, Scientific Reports and International Journal of Cancer.

In The Last Decade

Luoqi Jia

13 papers receiving 446 citations

Peers

Luoqi Jia

ONCOL

PHARM

EPIDE

Shi-Bing Su China

Boon Shing Tan Malaysia

Myeongjin Jeon South Korea

Sung‐Eun Hong South Korea

Débora Kristina Alves-Fernandes Brazil

Shun-Fa Yang Taiwan

Masato Komatsu Japan

Yingchun He China

Youxiang Ding China

Rachana Trivedi India

Shi-Bing Su China

Luoqi Jia

249 ×0.9

82 ×0.7

ONCOL

113 ×0.9

87 ×1.6

PHARM

48 ×1.0

EPIDE

Citations per year, relative to Luoqi Jia Luoqi Jia (= 1×) peers Shi-Bing Su

Countries citing papers authored by Luoqi Jia

Since Specialization

Citations

This map shows the geographic impact of Luoqi Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luoqi Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luoqi Jia more than expected).

Fields of papers citing papers by Luoqi Jia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luoqi Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luoqi Jia. The network helps show where Luoqi Jia may publish in the future.

Co-authorship network of co-authors of Luoqi Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Luoqi Jia. A scholar is included among the top collaborators of Luoqi Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luoqi Jia. Luoqi Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Jia, Luoqi, Jiayi Zhou, Hongbo Zhao, et al.. (2017). Corilagin sensitizes epithelial ovarian cancer to chemotherapy by inhibiting Snail-glycolysis pathways. Oncology Reports. 38(4). 2464–2470. 20 indexed citations

Zhang, Xuyin, Luoqi Jia, Xiang Tao, Jingxin Ding, & Keqin Hua. (2017). Intraoperative nerve staining in nerve-sparing radical hysterectomy: a pilot study. Archives of Gynecology and Obstetrics. 295(3). 737–741. 4 indexed citations

Tan, Jinyun, Luoqi Jia, Weihao Shi, et al.. (2016). Rab5a-mediated autophagy regulates the phenotype and behavior of vascular smooth muscle cells. Molecular Medicine Reports. 14(5). 4445–4453. 14 indexed citations

Jia, Luoqi, Hongyan Jin, Minzhi Lv, et al.. (2015). Abstract 5550: Corilagin, an anti-tumor herb medicine, sensitizes paclitaxel and carboplatin by primarily inhibiting glycolysis pathways in epithelial ovarian cancer. Cancer Research. 75(15_Supplement). 5550–5550. 3 indexed citations

Zhu, Kai, Qi Pan, Luoqi Jia, et al.. (2014). MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells. Scientific Reports. 4(1). 5524–5524. 68 indexed citations

Liu, Jun, Haiyan Zhang, Luoqi Jia, & Hong Sun. (2014). Effects of Treg cells and IDO on human epithelial ovarian cancer cells under hypoxic conditions. Molecular Medicine Reports. 11(3). 1708–1714. 14 indexed citations

Jia, Luoqi, Hongyan Jin, Jiayi Zhou, et al.. (2013). A potential anti-tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF-β signaling pathways. BMC Complementary and Alternative Medicine. 13(1). 33–33. 89 indexed citations

Liu, Yingtao, Xiang Tao, Luoqi Jia, et al.. (2012). Knockdown of RAB25 promotes autophagy and inhibits cell growth in ovarian cancer cells. Molecular Medicine Reports. 6(5). 1006–1012. 34 indexed citations

Zhang, Xuyin, et al.. (2012). Biomarker expression in normal fimbriae: Comparison of high- and low-grade serous ovarian carcinoma. Oncology Letters. 4(5). 1008–1012. 1 indexed citations

10.

Jia, Luoqi, Hongyan Jin, Jiayi Zhou, et al.. (2012). Abstract 1931: A potential antitumor herb medicine, Corilagin, inhibits ovarian cancer cell growth by blockage of TGF-β/AKT/ERK signaling pathways. Cancer Research. 72(8_Supplement). 1931–1931. 1 indexed citations

11.

Liu, Yingtao, Xiang Tao, Lingling Fan, et al.. (2012). Knockdown of mediator complex subunit 19 inhibits the growth of ovarian cancer. Molecular Medicine Reports. 6(5). 1050–1056. 9 indexed citations

12.

Jia, Luoqi, Hongyan Jin, Ming Yao, et al.. (2011). Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel. BMC Cancer. 11(1). 22–22. 62 indexed citations

13.

Jin, Hongyan, Yinhua Yu, Tao Zhang, et al.. (2009). Snail is critical for tumor growth and metastasis of ovarian carcinoma. International Journal of Cancer. 126(9). 2102–2111. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact